Form 8-K - Current report:
SEC Accession No. 0001140361-22-025333
Filing Date
2022-07-07
Accepted
2022-07-07 09:24:52
Documents
13
Period of Report
2022-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20004504x4_8k.htm   iXBRL 8-K 40121
2 EXHIBIT 99.1 ny20004504x4_ex99-1.htm EX-99.1 20421
  Complete submission text file 0001140361-22-025333.txt   207132

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20220707.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220707_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220707_pre.xml EX-101.PRE 16038
7 EXTRACTED XBRL INSTANCE DOCUMENT ny20004504x4_8k_htm.xml XML 4051
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221070776
SIC: 2835 In Vitro & In Vivo Diagnostic Substances